Round-up of SAFC's Glasgow conference

This content item was originally published on www.biopharma-reporter.com, a William Reed online publication.

By Natalie morrison

- Last updated on GMT

Related tags: Management

SAFC will extend its focus on high potency production through a number of new investments.

The company – who recently expanded its potent API capabilities at its plant in Jerusalem, Israel – announced its plans for further expansion in the sector during its conference at its liquid media facility in Glasgow.

Members of the biopharma and chemicals company also delivered talks on the changing nature of biosimilars and biobetters in the industry and how companies can benefit from it.

In-pharmatechnologist caught up with SAFC’s VP, global sales, Archie Cullen, as well as Grant Boldt, director of European business development, for the latest news.

QC manager for the firm’s Irvine facility, Susan Longhorn, also spoke about the companies four key areas for quality management, as well as working with regulatory agencies in today’s market.

Related news

Show more

Related product

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Follow us